Overview

• President Donald Trump submitted to Congress a determination naming 23 countries as major drug transit or illicit drug‑producing nations, with Afghanistan, Bolivia, Burma, Colombia and Venezuela labeled as having failed demonstrably.
• The U.S. Embassy in New Delhi said it revoked and denied visas for certain Indian business executives over alleged fentanyl precursor trafficking, citing Immigration and Nationality Act sections 221(i), 212(a)(2)(C) and 214(b).
• The embassy said affected executives and close family members may be ineligible to travel to the United States and that unnamed executives tied to flagged companies will face heightened scrutiny in future visa applications.
• The latest steps build on earlier U.S. prosecutions of India‑based suppliers, including charges against Raxuter Chemicals, Athos Chemicals and executive Bhavesh Lathiya for conspiring to distribute fentanyl precursors.
• Trump singled out China as the world's largest source of precursor chemicals, and the State Department noted that inclusion on the list reflects geographic and economic risk factors rather than a government's level of cooperation.